YY1 and type 2 diabetes mellitus: The regulatory analysis highlighted the involvement of two TFs (RELA and YY1) and two miRNAs (hsa-mir-34a-5p and hsa-mir-15a-5p) in modulating the expression of cHKGs between Mpox and T2D (Fig. 4).